We are live on
!
Find out more
HS
HighVista Strategies Portfolio holdings
AUM
$362M
1-Year Est. Return
230.96%
This Fund
S&P 500
This Quarter
Est. Return
+15.86%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$219M
AUM Growth
+$95.8M
(+78%)
Cap. Flow
+$80.7M
Cap. Flow
% of AUM
36.91%
Top 10 Holdings %
Top 10 Hldgs %
33.7%
Holding
163
New
55
Increased
48
Reduced
23
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco DB Commodity Index Tracking Fund
DBC
|
+$32.3M |
| 2 |
AJRD
Aerojet Rocketdyne Holdings
AJRD
|
+$3.42M |
| 3 |
TXNM
TXNM Energy Inc
TXNM
|
+$3.29M |
| 4 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$3.26M |
| 5 |
Indivior Pharmaceuticals
INDV
|
+$2.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$4.25M |
| 2 |
Coupang
CPNG
|
+$4.1M |
| 3 |
OSH
Oak Street Health, Inc.
OSH
|
+$3.46M |
| 4 |
TGNA
TEGNA Inc
TGNA
|
+$2.44M |
| 5 |
First Horizon
FHN
|
+$2.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.57% |
| 2 | Technology | 13.44% |
| 3 | Communication Services | 5.29% |
| 4 | Consumer Discretionary | 4.52% |
| 5 | Financials | 3.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FISV
51
Fiserv Inc
FISV
$27.8B
| $953K | 0.44% |
7,553
+1,871
| +33% | +$220K |
|
52
Lithia Motors
LAD
$8.35B
| $943K | 0.43% |
+3,101
| New | +$743K |
|
|
ALPN
53
DELISTED
Alpine Immune Sciences Inc
ALPN
| $928K | 0.42% |
90,287
| – | – |
|
54
PennyMac Financial
PFSI
$3.94B
| $924K | 0.42% |
+13,137
| New | +$832K |
|
55
Roper Technologies
ROP
$39.9B
| $920K | 0.42% |
1,913
+1,183
| +162% | +$536K |
|
|
MRUS
56
DELISTED
Merus
MRUS
| $896K | 0.41% |
34,027
-11,930
| -26% | -$261K |
|
|
WCC
57
WESCO International
WCC
$17.9B
| $895K | 0.41% |
4,997
+3,137
| +169% | +$457K |
|
58
Aclaris Therapeutics
ACRS
$867M
| $893K | 0.41% |
86,103
-111,700
| -56% | -$1.01M |
|
59
Laureate Education
LAUR
$5.13B
| $858K | 0.39% |
71,007
+45,107
| +174% | +$541K |
|
60
First Citizens BancShares
FCNCA
$25.4B
| $848K | 0.39% |
+661
| New | +$765K |
|
61
Celldex Therapeutics
CLDX
$3.37B
| $839K | 0.38% |
24,742
| – | – |
|
62
Trip.com Group
TCOM
$29.7B
| $831K | 0.38% |
+23,729
| New | +$825K |
|
|
ETNB
63
DELISTED
89bio
ETNB
| $827K | 0.38% |
+43,639
| New | +$766K |
|
64
Biomea Fusion
BMEA
$92.1M
| $825K | 0.38% |
+37,600
| New | +$1.18M |
|
65
Palo Alto Networks
PANW
$314B
| $819K | 0.37% |
+6,410
| New | +$667K |
|
66
Protagonist Therapeutics
PTGX
$9.71B
| $806K | 0.37% |
+29,179
| New | +$730K |
|
67
Huazhu Hotels Group
HTHT
$13.2B
| $804K | 0.37% |
+20,729
| New | +$901K |
|
68
Baidu
BIDU
$37.1B
| $792K | 0.36% |
+5,786
| New | +$758K |
|
69
Bausch Health
BHC
$2.37B
| $787K | 0.36% |
+98,351
| New | +$725K |
|
|
FOLD
70
DELISTED
Amicus Therapeutics
FOLD
| $786K | 0.36% |
62,581
-14,733
| -19% | -$175K |
|
71
Duolingo
DUOL
$6.42B
| $781K | 0.36% |
+5,467
| New | +$783K |
|
72
Alnylam Pharmaceuticals
ALNY
$29B
| $770K | 0.35% |
4,056
| – | – |
|
73
AnaptysBio
ANAB
$1.64B
| $766K | 0.35% |
37,651
+12,432
| +49% | +$252K |
|
|
FYBR
74
DELISTED
Frontier Communications
FYBR
| $761K | 0.35% |
40,846
+32,016
| +363% | +$601K |
|
75
RXO
RXO
$3.52B
| $757K | 0.35% |
+33,383
| New | +$672K |
|
Similar funds
SIAG
WI
MS
WTFG
VIA
A6
PI
ACM
HighVista Strategies's Q2 2023 Portfolio in Review
As of Q2 2023, HighVista Strategies held 163 positions worth $219M, up 78% from $123M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
HighVista Strategies deployed $80.7M of net new capital in Q2 2023, opening 55 new positions and adding to 48 existing holdings. Its largest new stake was Aerojet Rocketdyne Holdings: 61,520 shares worth $3.38M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 67% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Travere Therapeutics, an estimated $1.75M trimmed.
- HighVista Strategies's largest Q2 2023 buy was Aerojet Rocketdyne Holdings: 61,520 shares worth $3.38M.
- HighVista Strategies added most to Invesco DB Commodity Index Tracking Fund in Q2 2023, an estimated $32.3M increase.
- HighVista Strategies's biggest Q2 2023 reduction was Travere Therapeutics, cutting an estimated $1.75M.
- HighVista Strategies fully exited iShares Russell 1000 Value ETF in Q2 2023, selling an estimated $4.25M.
- HighVista Strategies's ten largest holdings make up 34% of its $219M portfolio in Q2 2023.
- HighVista Strategies opened 55 new positions and closed 29 in Q2 2023.
- HighVista Strategies's portfolio value rose 78% quarter-over-quarter to $219M.
Based on HighVista Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.